← FDA DRUG APPROVALS

FDA NDA · NDA004122

SULFADIAZINE

Sponsor: LILLY

APPLICATION
NDA004122
TYPE
NDA
ORIGINAL APPROVAL
1941-08-26
LATEST ACTION
1986-10-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SULFADIAZINE · ReferenceDiscontinued
SULFADIAZINE 500MG · TABLET · ORAL

Approval history

1986-10-01Labeling · Supplement 6 · standardAP
1985-11-22Labeling · Supplement 8 · standardAP
1978-01-12Labeling · Supplement 5 · standardAP
1941-08-26Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →